×
Investor Relations. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: ...
Events & Presentations. Upcoming Events. Apr 25 2024 at 10:00 AM EDT. Apr 25 2024 at 10:00 AM EDT. Chemed Corporation First-Quarter 2024 Earnings Conference ...
VP, Investor Relations. Kurt Bonner. Manager, Investor Relations. Lori Ursomarso. Investor Relations. +1.302.773.2263 investor@chemours.com.
Missing: che | Show results with:che
The Investor Relations website contains information about Exelon Corporation's business for stockholders, potential investors, and financial analysts.
Missing: che | Show results with:che
Welcome. Cheche Group Inc. (CCG) started its business in 2014 with the goal of transforming China's auto insurance market and digitalizing the end-to-end ...
Focused on delivering long-term investor returns ; Company Information. Ignite Strategy · ESG · Annual Financial Goals · Portfolio ; Stock Information. Stock ...
Missing: che | Show results with:che
People also ask
Events ; April 2024. Breaking New Ground: Chemomab Expert Perspectives on Primary Sclerosing Cholangitis (PSC) · Wednesday, April 10, 2024. 10:00am EDT ; March ...
See the company profile for Chemed Corporation (CHE) ... Chemed Corporation (CHE). Follow. 616.51 +12.09 (+ ... Director of Investor Relations, --, --, --. Mr. Brian ...
Our units are traded on the Toronto Stock Exchange under the symbol CHE. ... Join our Investor Relations mailing list. Enter ... Investors financial report pdf-icon ...
Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need.